Back to today’s briefing

Story perspectives

GLP-1 Weight-Loss Drugs Cut Daily Steps, Study Finds

6/15/2026

26 6 Full Breakdown

Summary

Story summary

Researchers at ENDO 2026 said people with obesity using GLP-1 agonists such as Ozempic and Wegovy reduced daily steps.
Data from the NIH All of Us program on 753 participants showed steps fell from 5,047 to 4,487 and moderate-vigorous minutes dropped from 28 to 22 per day.
Dr. Sajana Maharjan said the results highlight that exercise must accompany medication, with the steepest declines among men and those reporting joint pain.

1 of 1

Story summary

Researchers at ENDO 2026 said people with obesity using GLP-1 agonists such as Ozempic and Wegovy reduced daily steps.
Data from the NIH All of Us program on 753 participants showed steps fell from 5,047 to 4,487 and moderate-vigorous minutes dropped from 28 to 22 per day.
Dr. Sajana Maharjan said the results highlight that exercise must accompany medication, with the steepest declines among men and those reporting joint pain.